REG - PureTech Health PLC - Transaction in Own Shares
01/11/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231101:nRSA9279Ra&default-theme=true
RNS Number : 9279R PureTech Health PLC 01 November 2023
1 November 2023
PureTech Health plc
Transaction in Own Shares
PureTech Health PLC (the "Company") announces that it has purchased the
following number of its ordinary shares of one pence each through Jefferies
International Limited ("Jefferies"), as part of its Share Buyback Programme,
details of which were announced on 9 May 2022.
Date of purchase: 31 October 2023
Number of ordinary shares purchased: 49,200
Highest price paid per share: 158.60p
Lowest price paid per share: 151.40p
Volume weighted average price paid per share: 154.92p
PureTech intends to retain the purchased shares in treasury.
Following the above transaction, the Company will have 15,963,277 ordinary
shares in treasury and has 273,504,882 ordinary shares in issue (excluding
treasury shares). The total number of voting rights in the Company is
therefore 273,504,882 which may be used by shareholders in their calculations
to determine if they are required to notify their interest in, or a change to
their interest in, PureTech Health plc under the FCA's Disclosure Guidance and
Transparency Rules.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as
incorporated into UK domestic law by the European Union (Withdrawal) Act 2018)
(the Market Abuse Regulation), detailed information about the individual
purchases is available below.
About PureTech Health
PureTech is a clinical-stage biotherapeutics company dedicated to giving life
to new classes of medicine to change the lives of patients with devastating
diseases. The Company has created a broad and deep pipeline through its
experienced research and development team and its extensive network of
scientists, clinicians and industry leaders that is being advanced both
internally and through its Founded Entities. PureTech's R&D engine has
resulted in the development of 27 therapeutics and therapeutic candidates,
including two (Plenity® and EndeavorRx®) that have received both U.S.
FDA clearance and European marketing authorization and a third (KarXT) that
has been filed for FDA approval. A number of these programs are being advanced
by PureTech or its Founded Entities in various indications and stages of
clinical development, including registration enabling studies. All of the
underlying programs and platforms that resulted in this pipeline of
therapeutic candidates were initially identified or discovered and then
advanced by the PureTech team through key validation points.
For more information, visit www.puretechhealth.com
(http://www.puretechhealth.com/) or connect with us on X, formerly known as
Twitter, @puretechh.
Contact:
PureTech
Investor Relations
IR@puretechhealth.com
Individual Transactions
Transaction Date Transaction Time Volume Price (GBp) Platform Transaction Reference Number
31/10/2023 09:58:57 202 157.2 AQXE 00376203297TRLO0.1.1
31/10/2023 09:58:57 48 157.2 AQXE 00376203298TRLO0.1.1
31/10/2023 11:24:57 1000 158.6 XLON 00376214975TRLO0.1.1
31/10/2023 11:41:18 430 157.2 CHIX 00376216933TRLO0.1.1
31/10/2023 11:41:18 70 157.2 CHIX 00376216934TRLO0.1.1
31/10/2023 11:48:29 500 157.2 XLON 00376218023TRLO0.1.1
31/10/2023 11:48:30 53 157.2 XLON 00376218024TRLO0.1.1
31/10/2023 11:48:30 947 157.2 XLON 00376218025TRLO0.1.1
31/10/2023 11:52:02 226 157.2 CHIX 00376218346TRLO0.1.1
31/10/2023 11:55:39 104 157.2 CHIX 00376218636TRLO0.1.1
31/10/2023 11:55:39 134 157.2 CHIX 00376218637TRLO0.1.1
31/10/2023 12:01:48 171 157.2 AQXE 00376219199TRLO0.1.1
31/10/2023 12:02:15 654 158.2 XLON 00376219368TRLO0.1.1
31/10/2023 12:03:14 495 158.2 XLON 00376219499TRLO0.1.1
31/10/2023 12:03:14 851 158.2 XLON 00376219500TRLO0.1.1
31/10/2023 12:10:26 1329 158 XLON 00376220423TRLO0.1.1
31/10/2023 12:10:26 171 158 XLON 00376220422TRLO0.1.1
31/10/2023 12:10:27 115 157.8 XLON 00376220429TRLO0.1.1
31/10/2023 12:10:27 4 157.8 XLON 00376220430TRLO0.1.1
31/10/2023 12:19:07 26 157.8 BATE 00376221344TRLO0.1.1
31/10/2023 12:23:26 351 157.8 BATE 00376221963TRLO0.1.1
31/10/2023 12:23:26 149 157.8 BATE 00376221964TRLO0.1.1
31/10/2023 12:27:50 500 157.8 XLON 00376222316TRLO0.1.1
31/10/2023 12:36:52 12 158 CHIX 00376224623TRLO0.1.1
31/10/2023 12:36:53 53 158 XLON 00376224626TRLO0.1.1
31/10/2023 12:41:54 256 158 CHIX 00376225215TRLO0.1.1
31/10/2023 12:41:54 58 158 CHIX 00376225214TRLO0.1.1
31/10/2023 12:41:54 947 158 XLON 00376225216TRLO0.1.1
31/10/2023 12:51:13 11 157.8 XLON 00376226127TRLO0.1.1
31/10/2023 12:51:13 489 157.8 XLON 00376226129TRLO0.1.1
31/10/2023 12:51:14 53 157.8 XLON 00376226130TRLO0.1.1
31/10/2023 12:51:14 458 157.8 XLON 00376226131TRLO0.1.1
31/10/2023 13:14:11 20 157.2 CHIX 00376228599TRLO0.1.1
31/10/2023 13:32:22 1000 157.2 XLON 00376232650TRLO0.1.1
31/10/2023 13:32:25 410 157.2 CHIX 00376232658TRLO0.1.1
31/10/2023 13:32:25 154 157.2 AQXE 00376232660TRLO0.1.1
31/10/2023 13:32:25 31 157.2 AQXE 00376232659TRLO0.1.1
31/10/2023 13:32:25 202 157.2 AQXE 00376232661TRLO0.1.1
31/10/2023 13:32:25 81 157.2 TRQX 00376232663TRLO0.1.1
31/10/2023 13:32:25 81 157.2 TRQX 00376232662TRLO0.1.1
31/10/2023 13:32:27 369 156.8 BATE 00376232707TRLO0.1.1
31/10/2023 13:32:27 377 156.2 BATE 00376232709TRLO0.1.1
31/10/2023 13:32:27 236 156.8 BATE 00376232708TRLO0.1.1
31/10/2023 13:32:27 81 156.2 TRQX 00376232710TRLO0.1.1
31/10/2023 13:37:09 160 155.2 XLON 00376235021TRLO0.1.1
31/10/2023 13:42:23 220 155 AQXE 00376237879TRLO0.1.1
31/10/2023 13:47:32 1500 156 XLON 00376240380TRLO0.1.1
31/10/2023 14:00:35 324 155.4 XLON 00376251093TRLO0.1.1
31/10/2023 14:02:43 1176 155.4 XLON 00376252752TRLO0.1.1
31/10/2023 14:05:14 500 154.8 XLON 00376254333TRLO0.1.1
31/10/2023 14:05:14 1000 154.8 XLON 00376254332TRLO0.1.1
31/10/2023 14:05:14 123 154.8 CHIX 00376254335TRLO0.1.1
31/10/2023 14:05:14 400 154.8 XLON 00376254334TRLO0.1.1
31/10/2023 14:05:14 82 154.8 CHIX 00376254336TRLO0.1.1
31/10/2023 14:07:22 225 154.8 CHIX 00376255786TRLO0.1.1
31/10/2023 14:07:22 81 154.6 TRQX 00376255788TRLO0.1.1
31/10/2023 14:07:22 38 154.4 XLON 00376255792TRLO0.1.1
31/10/2023 14:14:13 1500 154.6 XLON 00376260553TRLO0.1.1
31/10/2023 14:16:21 1500 154.6 XLON 00376261896TRLO0.1.1
31/10/2023 14:17:45 377 154.4 BATE 00376262601TRLO0.1.1
31/10/2023 14:17:45 1272 154.4 XLON 00376262600TRLO0.1.1
31/10/2023 14:24:26 500 153.6 XLON 00376265915TRLO0.1.1
31/10/2023 14:24:26 81 153.6 TRQX 00376265917TRLO0.1.1
31/10/2023 14:27:54 500 153.8 XLON 00376268033TRLO0.1.1
31/10/2023 14:51:00 500 154.6 XLON 00376281184TRLO0.1.1
31/10/2023 14:54:39 500 154.6 XLON 00376283525TRLO0.1.1
31/10/2023 14:58:24 515 154.8 XLON 00376285266TRLO0.1.1
31/10/2023 14:58:50 638 154.8 XLON 00376285407TRLO0.1.1
31/10/2023 14:58:50 282 154.8 XLON 00376285408TRLO0.1.1
31/10/2023 14:58:50 80 154.8 XLON 00376285409TRLO0.1.1
31/10/2023 14:58:56 184 155.6 AQXE 00376285468TRLO0.1.1
31/10/2023 15:07:22 29 154.2 CHIX 00376288121TRLO0.1.1
31/10/2023 15:12:08 401 154.2 CHIX 00376289495TRLO0.1.1
31/10/2023 15:17:06 202 154.2 AQXE 00376291021TRLO0.1.1
31/10/2023 15:17:06 48 154.2 AQXE 00376291024TRLO0.1.1
31/10/2023 15:21:40 430 154.2 CHIX 00376292145TRLO0.1.1
31/10/2023 15:21:40 70 154.2 CHIX 00376292146TRLO0.1.1
31/10/2023 15:22:34 337 154.2 XLON 00376292368TRLO0.1.1
31/10/2023 15:22:34 119 154.2 XLON 00376292369TRLO0.1.1
31/10/2023 15:22:35 237 154.2 CHIX 00376292373TRLO0.1.1
31/10/2023 15:25:33 154 154.2 AQXE 00376293328TRLO0.1.1
31/10/2023 15:25:33 123 154.2 CHIX 00376293329TRLO0.1.1
31/10/2023 15:25:33 377 154.2 BATE 00376293330TRLO0.1.1
31/10/2023 15:25:33 377 154.2 BATE 00376293331TRLO0.1.1
31/10/2023 15:25:33 1044 154.2 XLON 00376293332TRLO0.1.1
31/10/2023 15:25:33 956 154.2 XLON 00376293333TRLO0.1.1
31/10/2023 15:30:12 1500 154 XLON 00376296999TRLO0.1.1
31/10/2023 15:30:15 377 154 BATE 00376297016TRLO0.1.1
31/10/2023 15:30:15 112 154 BATE 00376297017TRLO0.1.1
31/10/2023 15:30:15 80 153.4 TRQX 00376297018TRLO0.1.1
31/10/2023 15:30:15 81 153.4 TRQX 00376297019TRLO0.1.1
31/10/2023 15:32:22 1499 152.6 XLON 00376299468TRLO0.1.1
31/10/2023 15:32:23 1 152.6 XLON 00376299480TRLO0.1.1
31/10/2023 15:44:06 198 152 XLON 00376304524TRLO0.1.1
31/10/2023 15:44:19 120 152 XLON 00376304571TRLO0.1.1
31/10/2023 15:51:19 501 152 XLON 00376307490TRLO0.1.1
31/10/2023 15:54:49 999 153.6 XLON 00376308518TRLO0.1.1
31/10/2023 15:55:22 118 153.6 XLON 00376308701TRLO0.1.1
31/10/2023 15:55:22 106 153.6 XLON 00376308702TRLO0.1.1
31/10/2023 15:55:50 166 153.6 XLON 00376308844TRLO0.1.1
31/10/2023 15:56:53 219 153.6 XLON 00376309186TRLO0.1.1
31/10/2023 15:57:38 390 153.6 XLON 00376309442TRLO0.1.1
31/10/2023 15:57:38 207 153.6 XLON 00376309443TRLO0.1.1
31/10/2023 15:57:59 58 153.6 XLON 00376309518TRLO0.1.1
31/10/2023 15:58:41 153 153.6 XLON 00376309732TRLO0.1.1
31/10/2023 15:59:24 145 153.6 XLON 00376309918TRLO0.1.1
31/10/2023 15:59:24 164 153.6 XLON 00376309917TRLO0.1.1
31/10/2023 16:00:24 123 153.6 XLON 00376310378TRLO0.1.1
31/10/2023 16:00:24 114 153.6 XLON 00376310379TRLO0.1.1
31/10/2023 16:00:45 63 153.6 XLON 00376310505TRLO0.1.1
31/10/2023 16:01:26 151 153.6 XLON 00376310749TRLO0.1.1
31/10/2023 16:01:26 328 153.6 XLON 00376310748TRLO0.1.1
31/10/2023 16:02:05 125 153.6 XLON 00376310931TRLO0.1.1
31/10/2023 16:03:04 471 153.6 XLON 00376311378TRLO0.1.1
31/10/2023 16:03:04 110 153.6 XLON 00376311379TRLO0.1.1
31/10/2023 16:04:03 12 153.6 XLON 00376311723TRLO0.1.1
31/10/2023 16:04:27 2500 152.8 XLON 00376311880TRLO0.1.1
31/10/2023 16:04:27 179 152.6 CHIX 00376311881TRLO0.1.1
31/10/2023 16:04:27 1 152.6 CHIX 00376311882TRLO0.1.1
31/10/2023 16:04:27 5 152.6 CHIX 00376311883TRLO0.1.1
31/10/2023 16:04:27 14 152.6 CHIX 00376311884TRLO0.1.1
31/10/2023 16:06:12 231 152.6 CHIX 00376312587TRLO0.1.1
31/10/2023 16:06:12 47 152.6 TRQX 00376312589TRLO0.1.1
31/10/2023 16:09:30 202 152.2 AQXE 00376313777TRLO0.1.1
31/10/2023 16:09:30 488 152.2 XLON 00376313778TRLO0.1.1
31/10/2023 16:09:30 500 152.2 XLON 00376313779TRLO0.1.1
31/10/2023 16:10:55 43 152 XLON 00376314295TRLO0.1.1
31/10/2023 16:12:11 202 152 AQXE 00376314708TRLO0.1.1
31/10/2023 16:12:11 258 152 BATE 00376314710TRLO0.1.1
31/10/2023 16:12:11 115 152 BATE 00376314709TRLO0.1.1
31/10/2023 16:12:11 457 152 XLON 00376314712TRLO0.1.1
31/10/2023 16:12:11 269 152 BATE 00376314711TRLO0.1.1
31/10/2023 16:12:11 500 152 XLON 00376314713TRLO0.1.1
31/10/2023 16:13:00 265 151.8 XLON 00376314936TRLO0.1.1
31/10/2023 16:14:31 430 151.8 CHIX 00376315535TRLO0.1.1
31/10/2023 16:14:31 648 151.8 XLON 00376315536TRLO0.1.1
31/10/2023 16:14:40 16 151.4 TRQX 00376315617TRLO0.1.1
31/10/2023 16:14:40 65 151.4 TRQX 00376315618TRLO0.1.1
31/10/2023 16:20:07 2 152.2 XLON 00376317793TRLO0.1.1
31/10/2023 16:28:18 1 152 CHIX 00376320833TRLO0.1.1
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSFLFLDIDLLVIVRecent news on Puretech Health
See all newsREG - PureTech Health PLC - Total Voting Rights
AnnouncementREG - PureTech Health PLC - Final Results
AnnouncementREG - PureTech Health PLC - Notice of Results
AnnouncementRCS - PureTech Health PLC - PRTC LYT-100 Ph2b in IPF Enrolled; Results Q4 2024
AnnouncementRCS - PureTech Health PLC - FDA Grants PRTC's LYT-200 Fast Track Designation
Announcement